Principal Financial Group Inc Adma Biologics, Inc. Transaction History

Principal Financial Group Inc

$176 Billion
Q2 2025

A detailed history of Principal Financial Group Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 1,546,435 shares of ADMA stock, worth $23.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,546,435

Previous 1,288,121 20.05%

Holding current value

$23.6 Million

Previous $25.6 Million 10.19%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$17.6 - $24.51 $4.55 Million - $6.33 Million	258,314 Added 20.05%	1,546,435 $28.2 Million
Q1 2025 Apr 28, 2025	BUY	$15.44 - $20.61 $449,412 - $599,895	29,107 Added 2.31%	1,288,121 $25.6 Million
Q4 2024 Jan 31, 2025	BUY	$15.62 - $22.62 $19.7 Million - $28.5 Million	1,259,014 New	1,259,014 $21.6 Million
Q3 2024 Oct 31, 2024	BUY	$11.21 - $20.03 $11.9 Million - $21.2 Million	1,059,394 Added 785.74%	1,194,221 $23.9 Million
Q2 2024 Jul 29, 2024	SELL	$5.98 - $11.18 $8,569 - $16,020	-1,433 Reduced 1.05%	134,827 $1.51 Million
Q1 2024 Apr 29, 2024	SELL	$4.4 - $6.74 $98,445 - $150,800	-22,374 Reduced 14.1%	136,260 $899,000
Q4 2023 Feb 07, 2024	BUY	$3.08 - $4.52 $73,439 - $107,774	23,844 Added 17.69%	158,634 $717,000
Q3 2023 Nov 02, 2023	BUY	$3.47 - $4.61 $104,405 - $138,705	30,088 Added 28.74%	134,790 $482,000
Q2 2023 Aug 07, 2023	BUY	$3.12 - $4.22 $6,942 - $9,389	2,225 Added 2.17%	104,702 $386,000
Q1 2023 May 09, 2023	SELL	$3.01 - $3.87 $20,085 - $25,824	-6,673 Reduced 6.11%	102,477 $339,000
Q4 2022 Feb 09, 2023	BUY	$2.47 - $3.88 $72,524 - $113,924	29,362 Added 36.8%	109,150 $423,000
Q3 2022 Nov 09, 2022	SELL	$2.03 - $2.86 $110,809 - $156,115	-54,586 Reduced 40.62%	79,788 $194,000
Q2 2022 Aug 10, 2022	BUY	$1.43 - $2.2 $170,646 - $262,532	119,333 Added 793.38%	134,374 $266,000
Q1 2022 May 09, 2022	SELL	$1.28 - $1.83 $1,084 - $1,550	-847 Reduced 5.33%	15,041 $28,000
Q4 2021 Feb 09, 2022	SELL	$1.09 - $1.66 $3,156 - $4,807	-2,896 Reduced 15.42%	15,888 $22,000
Q3 2021 Nov 09, 2021	SELL	$1.13 - $1.65 $3,438 - $5,020	-3,043 Reduced 13.94%	18,784 $21,000
Q2 2021 Aug 10, 2021	SELL	$1.51 - $2.07 $511,412 - $701,075	-338,684 Reduced 93.95%	21,827 $34,000
Q1 2021 May 10, 2021	BUY	$1.67 - $2.95 $41,671 - $73,611	24,953 Added 7.44%	360,511 $634,000
Q4 2020 Feb 08, 2021	BUY	$1.8 - $2.56 $348,008 - $494,945	193,338 Added 135.94%	335,558 $655,000
Q3 2020 Nov 06, 2020	BUY	$2.04 - $3.74 $119,193 - $218,520	58,428 Added 69.73%	142,220 $339,000
Q2 2020 Aug 05, 2020	BUY	$2.42 - $3.29 $202,776 - $275,675	83,792 New	83,792 $246,000

Others Institutions Holding ADMA

# of Institutions

401

Shares Held

191M

Call Options Held

2.08M

Put Options Held

1.56M

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Adma Biologics, Inc. Transaction History